Aminoguanidine nitrate is primarily used in research settings as a selective inhibitor of advanced glycation end-products (AGEs), which are implicated in various chronic diseases such as diabetes and aging-related complications. It is studied for its potential to mitigate diabetic complications like nephropathy, retinopathy, and neuropathy by preventing the formation of AGEs. Additionally, it is utilized in the synthesis of pharmaceuticals and organic compounds, particularly in the development of drugs targeting oxidative stress and inflammation. In material science, it serves as a precursor in the production of energetic materials and explosives due to its nitrate component. Its antioxidant properties also make it a candidate for investigating therapeutic interventions in neurodegenerative diseases and cardiovascular disorders.